We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+11.76%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.08B
AUM Growth
+$20.7M
Cap. Flow
-$60.6M
Cap. Flow %
-5.62%
Top 10 Hldgs %
20.95%
Holding
208
New
36
Increased
50
Reduced
44
Closed
33

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$22.8M
2
LEGN icon
Legend Biotech
LEGN
+$18.8M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$16.1M
4
SWTX
SpringWorks Therapeutics
SWTX
+$16M
5
UTHR icon
United Therapeutics
UTHR
+$15.2M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$20M
2
HQY icon
HealthEquity
HQY
+$18.6M
3
ESI icon
Element Solutions
ESI
+$17.4M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.2M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 44.2%
2 Technology 15.96%
3 Industrials 9.72%
4 Energy 6.59%
5 Consumer Staples 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTN icon
151
Marten Transport
MRTN
$1.22B
$209K 0.02%
+10,883
New +$218K
CRM icon
152
Salesforce
CRM
$158B
$202K 0.02%
+1,405
New +$238K
SLGCW
153
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$12K ﹤0.01%
27,148
– –
AFG icon
154
American Financial Group
AFG
$12.1B
– –
-57,856
Closed -$8.03M
AM icon
155
Antero Midstream
AM
$10.1B
– –
-18,222
Closed -$165K
BOOT icon
156
Boot Barn
BOOT
$4.95B
– –
-67,819
Closed -$4.67M
BPOP icon
157
Popular Inc
BPOP
$11.1B
– –
-4,948
Closed -$381K
CLAR icon
158
Clarus
CLAR
$143M
– –
-651,775
Closed -$12.4M
CMG icon
159
Chipotle Mexican Grill
CMG
$41.5B
– –
-21,200
Closed -$554K
DBRG icon
160
DigitalBridge
DBRG
$2.95B
– –
-334,490
Closed -$6.53M
ELS icon
161
Equity Lifestyle Properties
ELS
$12.6B
– –
-83,051
Closed -$5.85M
ESI icon
162
Element Solutions
ESI
$9.23B
– –
-979,104
Closed -$17.4M
EXAS
163
DELISTED
Exact Sciences
EXAS
– –
-115,092
Closed -$4.53M
FIGS icon
164
FIGS
FIGS
$2.37B
– –
-204,996
Closed -$1.87M
HQY icon
165
HealthEquity
HQY
$8.75B
– –
-303,179
Closed -$18.6M
IIPR icon
166
Innovative Industrial Properties
IIPR
$1.72B
– –
-75,320
Closed -$8.28M
JAZZ icon
167
Jazz Pharmaceuticals
JAZZ
$16.7B
– –
-30,552
Closed -$4.77M
LVTX
168
DELISTED
LAVA Therapeutics
LVTX
– –
-450,556
Closed -$1.29M
MASS icon
169
908 Devices
MASS
$364M
– –
-551,895
Closed -$11.4M
MOS icon
170
The Mosaic Company
MOS
$7.33B
– –
-30,189
Closed -$1.43M
MP icon
171
MP Materials
MP
$9.1B
– –
-74,801
Closed -$2.4M
MTCH icon
172
Match Group
MTCH
$8.55B
– –
-9,043
Closed -$630K
PZZA icon
173
Papa John's
PZZA
$806M
– –
-17,370
Closed -$1.45M
RARE icon
174
Ultragenyx Pharmaceutical
RARE
$2.55B
– –
-229,492
Closed -$13.7M
SFM icon
175
Sprouts Farmers Market
SFM
$8.01B
– –
-114,662
Closed -$2.9M
4 5 6
7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Nicholas Investment Partners held 208 positions worth $1.08B, up 2% from $1.06B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners withdrew a net $60.6M in Q3 2022, closing 33 positions and reducing 44 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Cytokinetics worth $22.9M.

  • Nicholas Investment Partners's largest Q3 2022 buy was Cytokinetics: 472,839 shares worth $22.9M.
  • Nicholas Investment Partners added most to Callaway Golf Company in Q3 2022, an estimated $9.5M increase.
  • Nicholas Investment Partners's biggest Q3 2022 reduction was IVERIC bio, Inc. Common Stock, cutting an estimated $14.2M.
  • Nicholas Investment Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $20M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $1.08B portfolio in Q3 2022.
  • Nicholas Investment Partners opened 36 new positions and closed 33 in Q3 2022.
  • Nicholas Investment Partners's portfolio value rose 2% quarter-over-quarter to $1.08B.

Based on Nicholas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.